PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30075223-8	2018	In particular, we will focus our discussion on the FDA approved HDAC inhibitor valproic acid (VPA) which has been shown to alter proliferation, survival, cell migration, and hormone receptor expression of breast cancer cells in both the pre-clinical and clinical settings.	Valproic Acid	79-92	nuclear receptor subfamily 4 group A member 1	Homo sapiens	174-190	
30075223-8	2018	In particular, we will focus our discussion on the FDA approved HDAC inhibitor valproic acid (VPA) which has been shown to alter proliferation, survival, cell migration, and hormone receptor expression of breast cancer cells in both the pre-clinical and clinical settings.	Valproic Acid	94-97	nuclear receptor subfamily 4 group A member 1	Homo sapiens	174-190